Raymond James & Associates Uni Qure N.V. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$4.82 - $6.93 $119,810 - $172,259	-24,857 Reduced 47.6%	27,367 $142,000
Q4 2023 Jan 16, 2024	BUY	$5.63 - $8.27 $17,706 - $26,009	3,145 Added 6.41%	52,224 $353,000
Q3 2023 Oct 24, 2023	BUY	$6.71 - $11.83 $226,435 - $399,215	33,746 Added 220.09%	49,079 $329,000
Q2 2023 Jul 25, 2023	BUY	$11.12 - $22.2 $2,835 - $5,661	255 Added 1.69%	15,333 $175,000
Q1 2023 Apr 14, 2023	SELL	$18.7 - $23.07 $3,141 - $3,875	-168 Reduced 1.1%	15,078 $303,000
Q4 2022 Feb 08, 2023	SELL	$18.12 - $27.32 $4,457 - $6,720	-246 Reduced 1.59%	15,246 $345,000
Q3 2022 Oct 25, 2022	SELL	$16.98 - $25.54 $46,066 - $69,290	-2,713 Reduced 14.9%	15,492 $291,000
Q2 2022 Aug 12, 2022	SELL	$13.15 - $20.45 $74,599 - $116,012	-5,673 Reduced 23.76%	18,205 $339,000
Q1 2022 May 11, 2022	SELL	$14.54 - $21.5 $201,946 - $298,613	-13,889 Reduced 36.78%	23,878 $431,000
Q4 2021 Feb 08, 2022	SELL	$20.24 - $36.01 $122,553 - $218,040	-6,055 Reduced 13.82%	37,767 $783,000
Q3 2021 Nov 02, 2021	BUY	$26.01 - $38.22 $194,762 - $286,191	7,488 Added 20.61%	43,822 $1.4 Million
Q2 2021 Aug 11, 2021	BUY	$29.97 - $37.17 $842,606 - $1.05 Million	28,115 Added 342.07%	36,334 $1.12 Million
Q1 2021 May 14, 2021	BUY	$29.24 - $42.03 $240,323 - $345,444	8,219 New	8,219 $277,000
Q4 2020 Feb 12, 2021	SELL	$35.35 - $50.67 $393,728 - $564,362	-11,138 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$35.98 - $47.66 $165,364 - $219,045	4,596 Added 70.25%	11,138 $410,000
Q2 2020 Jul 28, 2020	BUY	$45.06 - $67.74 $43,573 - $65,504	967 Added 17.35%	6,542 $295,000
Q1 2020 Apr 21, 2020	SELL	$40.01 - $73.97 $37,489 - $69,309	-937 Reduced 14.39%	5,575 $265,000
Q4 2019 Feb 12, 2020	SELL	$37.13 - $74.62 $52,316 - $105,139	-1,409 Reduced 17.79%	6,512 $467,000
Q3 2019 Nov 07, 2019	BUY	$39.36 - $76.8 $311,770 - $608,332	7,921 New	7,921 $312,000

Others Institutions Holding QURE

# of Institutions

154

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

Vestal Point Capital, LP New York, NY

4.75M
Shares

$82.7 Million
1.78% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.78M
Shares

$48.4 Million
0.81% of portfolio
Boxer Capital, LLC San Diego, CA

2.23M
Shares

$38.7 Million
0.58% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.19M
Shares

$38.1 Million
0.01% of portfolio
Abrdn PLC

1.93M
Shares

$33.6 Million
0.02% of portfolio

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $813M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account